Patents Prove SARS-CoV-2 is a Manufactured Virus

STORY AT-A-GLANCE 

• Hundreds of patents show SARS-CoV-2 is a manmade virus that has been tinkered with for decades. Much of the research was funded by the National Institutes of Allergy and Infectious Diseases (NIAID) under the direction of Dr. Anthony Fauci, and may have been an outgrowth of attempts to develop an HIV vaccine
• In 1999, Fauci funded research at University of North Carolina Chapel Hill to create “an infectious replication-defective coronavirus†specifically targeted for human lung epithelium. This appears to be the virus that became known as SARS-CoV
• U.S. Patent 7279327 shows we knew the ACE receptor, the ACE2 binding domain, the S-1 spike protein, and other elements of SARS-CoV-2 were engineered and could be synthetically modified using gene sequencing technologies
• The CDC holds patents to a SARS coronavirus that is 89% to 99% identical to the sequence identified as SARS-CoV-2, as well as the PCR test to diagnose it
• 120 patents detail supposed “unique†features of SARS-CoV-2: the polybasic cleavage site, the spike protein and the ACE2 binding, proving it’s not a novel virus at all

He concluded by calling for greater transparency and accountability in the pandemic virus industrial complex.

He concludes by emphasizing the importance of taking preventative measures to protect ourselves from future pandemics.

SARS-CoV-2 Is Not a Novel Coronavirus at All

Martin’s company has developed a patent-based index that is used by venture capitalists and other investors to assess the risk of investing in new technologies. The index uses a proprietary algorithm to analyze patent data from multiple sources, including the US Patent and Trademark Office, to identify trends in technology development and potential areas of investment opportunity. The index also provides insights into the competitive landscape for emerging technologies, helping investors make informed decisions about where to invest their capital.

He also explains how the virus has been weaponized to target certain populations, such as the elderly and those with pre-existing conditions. Finally, he discusses the potential for a vaccine to be developed that could be used to protect people from this virus.

• “And what we found… are over 120 patented pieces of evidence, to suggest that the declaration of a ‘novel coronavirus’ was actually entirely a fallacy. There was no novel coronavirus… it’s not been novel for over two decades.” —David Martin, Ph.D.

irustype -19 29US10802057 B 1 :Methodsforidentifyingnovelantigensassociatedwithsevereacuterespiratorysyndromecoronavirustype -19 30US10802058 B 1 :Methodsforidentifyingnovelantigensassociatedwithsevereacuterespiratorysyndromecoronavirustype -19

Spike Protein Vaccine for Coronavirus Patented 22 Years Ago

• Baric’s work has been used to develop a vaccine candidate for SARS-CoV-2, the virus that causes COVID-19. His research has helped to identify the spike protein of SARS-CoV-2 as a potential target for vaccine development. This research has also provided insight into how the virus interacts with human cells and how it can be targeted by vaccines. In addition, Baric’s work has helped to inform the design of clinical trials for potential vaccines against SARS-CoV-2.

From HIV Vaccine Development to COVID-19

• The patent is important because it provides a detailed description of how to use gene sequencing technology to synthetically modify coronaviruses in the laboratory. This knowledge can be used to develop new treatments and vaccines for diseases caused by coronaviruses, such as COVID-19. The patent also provides insight into the genetic makeup of coronaviruses, which can help researchers better understand how they work and how to combat them.

Coronavirus — A Biological Weapon Candidate Since 2001?

• “Our concern was that coronavirus was being seen as not only a potential manipulatable agent for potential use as a vaccine vector, but it was also very clearly being considered as a biological weapon candidate,” Martin says.

  Before the SARS outbreak in China, Martin reported these concerns publicly. “So, you can imagine how disappointed I am to be sitting here … having 20 years earlier pointed that there was a problem looming on the horizon with respect to coronavirus,” he says.

CDC Holds Patents on SARS Coronavirus

The CDC was attempting to patent a strain of the Ebola virus, which is already in the public domain. This would have given them exclusive rights to the virus and allowed them to charge fees for its use. However, this is not allowed under US law as it violates the principle of prior art, which states that something cannot be patented if it has already been publicly disclosed or used.

“However, the CDC has released a partial sequence of SARS-CoV-2, which is available for public research. This partial sequence includes the full genome of the virus and can be used to study its structure and function.”

Sequoia Pharmaceuticals

I’m not sure what you mean by suspicious. If you are asking if it is suspicious that someone would want to buy a car for $1,000, then the answer would depend on the condition of the car and its market value.

Sanofi Holds Patents to Novel Feature of SARS-CoV-2

The patents are owned by a variety of companies, including Merck, GlaxoSmithKline, Sanofi-Aventis, and Pfizer. These companies have invested heavily in the development of new vaccines and have been granted exclusive rights to use their patented technologies for a certain period of time. This allows them to recoup their investments and make a profit from the sale of their products. As such, these patents are an important part of the vaccine industry and help ensure that new vaccines can be developed and brought to market quickly.

The patents have been used to develop treatments and vaccines for the virus, such as monoclonal antibodies, small interfering RNAs (siRNAs), and other antiviral agents. Additionally, the patents have been used to identify new targets for drug development, such as protease inhibitors and entry inhibitors. The patents have also been used to study the virus’s evolution and transmission dynamics, which can help inform public health strategies. Finally, the patents have been used to develop diagnostic tests for SARS-CoV-2, including rapid antigen tests and PCR tests.

Additionally, patenting the virus allowed them to receive recognition for their work and to be credited with its development.

The Pandemic Virus Industrial Complex Is Swimming in Profit

Dr. Peter Ben Embarek, WHO expert on animal diseases and zoonosis

• “We need to increase public understanding of the need for medical countermeasures such as a pan-coronavirus vaccine. A key driver is the media and the economics will follow the hype. We need to use that hype to our advantage, to get to the real issues. Investors will respond if they see profit at the end of the process.”

Intentional Weaponization of Spike Protein

‘New Normal’ Coined by Merck at 2004 Bioterrorism Conference

The board is responsible for providing independent advice to the World Bank, WHO, and UN on how to strengthen global preparedness for health emergencies. It also works to ensure that countries are better prepared to respond quickly and effectively when a health emergency arises.

Overall, the interview provides a comprehensive look into the history of the virus and how Fauci’s decisions have shaped our current understanding of it.

We will have access to more data than ever before, allowing us to make better decisions and create more efficient systems. We will be able to use technology to automate mundane tasks, freeing up our time for more meaningful pursuits. We will be able to leverage the power of the internet to connect with people from all over the world, creating a global community that is stronger and more resilient than ever before. Finally, we will have access to powerful tools that allow us to take control of our own lives and make decisions that are best for ourselves and our families.